Veradigm (NASDAQ:MDRX) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX) in a research note published on Wednesday. The firm issued a hold rating on the software maker’s stock.

Veradigm Stock Performance

Shares of Veradigm stock opened at $9.25 on Wednesday. The company’s 50 day moving average price is $9.59 and its two-hundred day moving average price is $9.06. Veradigm has a fifty-two week low of $5.01 and a fifty-two week high of $13.69.

Institutional Investors Weigh In On Veradigm

Hedge funds and other institutional investors have recently bought and sold shares of the company. Innealta Capital LLC bought a new position in Veradigm in the second quarter valued at about $38,000. Meadow Creek Wealth Advisors LLC acquired a new position in shares of Veradigm in the first quarter valued at approximately $83,000. Tyro Capital Management LLC acquired a new position in shares of Veradigm in the first quarter valued at approximately $9,055,000. Goldman Sachs Group Inc. raised its holdings in Veradigm by 6.6% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock valued at $16,749,000 after buying an additional 99,528 shares during the last quarter. Finally, Wellington Management Group LLP boosted its position in Veradigm by 117.8% during the 4th quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock worth $60,908,000 after buying an additional 3,140,483 shares during the period.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.